A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Healthy Adult Female Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Venetoclax
Related studies linked through entity extraction aliases.
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
- Status
- RECRUITING
- Phase
- PHASE2
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
BCL2i CLAG-M in R/R Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy
- Status
- RECRUITING
- Phase
- NA
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
- Status
- RECRUITING
- Phase
- PHASE2
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE1
Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
- Status
- RECRUITING
- Phase
- PHASE2
Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
- Status
- RECRUITING
- Phase
- PHASE2
Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML
- Status
- RECRUITING
- Phase
- PHASE2
Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL
- Status
- RECRUITING
- Phase
- PHASE2
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
- Status
- RECRUITING
- Phase
- PHASE2
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
- Status
- RECRUITING
- Phase
- PHASE2
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
- Status
- RECRUITING
- Phase
- PHASE2